3/17
10:29 am
crsp
Is Crispr Therapeutics (CRSP) The Best Gene-Editing Stock to Buy Now? [Yahoo! Finance]
Low
Report
Is Crispr Therapeutics (CRSP) The Best Gene-Editing Stock to Buy Now? [Yahoo! Finance]
3/17
09:46 am
crsp
CRISPR Therapeutics (CRSP) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $110.00 price target on the stock, up from $105.00.
Low
Report
CRISPR Therapeutics (CRSP) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $110.00 price target on the stock, up from $105.00.
3/14
08:12 pm
crsp
A Look At CRISPR Therapeutics (CRSP) Valuation After Upsized US$550 Million Convertible Note Offering [Yahoo! Finance]
Low
Report
A Look At CRISPR Therapeutics (CRSP) Valuation After Upsized US$550 Million Convertible Note Offering [Yahoo! Finance]
3/13
10:26 am
crsp
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know [Yahoo! Finance]
Low
Report
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know [Yahoo! Finance]
3/11
05:01 pm
crsp
CRISPR Therapeutics (CRSP) Reports $116M FY25 Revenue Driven by CASGEVY Growth [Yahoo! Finance]
Low
Report
CRISPR Therapeutics (CRSP) Reports $116M FY25 Revenue Driven by CASGEVY Growth [Yahoo! Finance]
3/11
07:13 am
crsp
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering [Yahoo! Finance]
Medium
Report
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering [Yahoo! Finance]
3/11
07:00 am
crsp
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
Medium
Report
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
3/11
01:31 am
crsp
CRISPR Therapeutics Raises US$350m As Undervalued Shares Draw Investor Focus [Yahoo! Finance]
Medium
Report
CRISPR Therapeutics Raises US$350m As Undervalued Shares Draw Investor Focus [Yahoo! Finance]
3/10
04:03 pm
crsp
This Is Why CRISPR Therapeutics Stock Is Tumbling on Tuesday [Yahoo! Finance]
Medium
Report
This Is Why CRISPR Therapeutics Stock Is Tumbling on Tuesday [Yahoo! Finance]
3/10
08:23 am
crsp
Here is Why CRISPR Therapeutics (CRSP) Appears so Good [Yahoo! Finance]
Low
Report
Here is Why CRISPR Therapeutics (CRSP) Appears so Good [Yahoo! Finance]
3/10
07:37 am
crsp
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering [Yahoo! Finance]
Low
Report
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering [Yahoo! Finance]
3/10
07:00 am
crsp
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
Low
Report
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
3/9
04:17 pm
crsp
Is A Vertex Buyout Of Crispr Therapeutics Inevitable? Here's My Take [Seeking Alpha]
Medium
Report
Is A Vertex Buyout Of Crispr Therapeutics Inevitable? Here's My Take [Seeking Alpha]
3/9
12:02 pm
crsp
CRISPR Therapeutics Pivots Beyond Casgevy, Highlights CTX310 Data and New Cardiovascular Push [Yahoo! Finance]
Low
Report
CRISPR Therapeutics Pivots Beyond Casgevy, Highlights CTX310 Data and New Cardiovascular Push [Yahoo! Finance]
3/7
07:22 am
crsp
CRISPR Therapeutics AG (CRSP) a Moderate Buy, Per Wall Street [Yahoo! Finance]
Medium
Report
CRISPR Therapeutics AG (CRSP) a Moderate Buy, Per Wall Street [Yahoo! Finance]
3/5
08:39 pm
crsp
CRISPR Therapeutics (CRSP) Is Down 7.1% After Slower Casgevy Rollout and Wider 2025 Net Loss – What's Changed [Yahoo! Finance]
Low
Report
CRISPR Therapeutics (CRSP) Is Down 7.1% After Slower Casgevy Rollout and Wider 2025 Net Loss – What's Changed [Yahoo! Finance]
3/4
02:07 pm
crsp
Forget CRISPR Therapeutics: This Gene-Editing Player Already Boasts the Profits It Dreams Of [Yahoo! Finance]
Low
Report
Forget CRISPR Therapeutics: This Gene-Editing Player Already Boasts the Profits It Dreams Of [Yahoo! Finance]
3/2
12:40 pm
crsp
Is CRISPR Therapeutics Stock Too Risky to Buy Right Now? [Yahoo! Finance]
Low
Report
Is CRISPR Therapeutics Stock Too Risky to Buy Right Now? [Yahoo! Finance]
3/1
10:03 am
crsp
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought [Yahoo! Finance]
Low
Report
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought [Yahoo! Finance]
2/28
02:32 am
crsp
Here's What Analysts Are Saying About CRISPR Therapeutics AG (CRSP) [Yahoo! Finance]
Low
Report
Here's What Analysts Are Saying About CRISPR Therapeutics AG (CRSP) [Yahoo! Finance]
2/26
04:14 pm
crsp
Assessing CRISPR Therapeutics (CRSP) Valuation After FDA Draft Guidance And Recent Weak Earnings [Yahoo! Finance]
Low
Report
Assessing CRISPR Therapeutics (CRSP) Valuation After FDA Draft Guidance And Recent Weak Earnings [Yahoo! Finance]
2/25
08:43 pm
crsp
FDA Draft Guidance Puts CRISPR Therapeutics Rare Disease Outlook In Focus [Yahoo! Finance]
High
Report
FDA Draft Guidance Puts CRISPR Therapeutics Rare Disease Outlook In Focus [Yahoo! Finance]
2/19
07:30 am
crsp
CRISPR Therapeutics touts zugo-cel CAR-T gains, eyes autoimmune expansion at Citi oncology summit [Yahoo! Finance]
Low
Report
CRISPR Therapeutics touts zugo-cel CAR-T gains, eyes autoimmune expansion at Citi oncology summit [Yahoo! Finance]
2/18
10:41 am
crsp
Should You Buy Shares of CRISPR Therapeutics in February? [Yahoo! Finance]
Low
Report
Should You Buy Shares of CRISPR Therapeutics in February? [Yahoo! Finance]
2/17
11:55 am
crsp
CRISPR Therapeutics Q4: The Elite Time To Buy Is In 2027 [Seeking Alpha]
Low
Report
CRISPR Therapeutics Q4: The Elite Time To Buy Is In 2027 [Seeking Alpha]